trilliant health glp-1 prescriptions 2024 Are Up, Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's Update GLP-1 therapies drive growth in
Description
When deciding what medications to cover, insurers consider how expenses affect monthly premiums for all plan members
Typical starting points: Liraglutide: 0.30.6 mg daily Semaglutide: 0.1250.25 mg weekly Tirzepatide (Mounjaro): 1.252.5 mg weekly (starting pen dose is 2.5 mg) Doses are adjusted every 46 weeks based on your appetite, energy, and any side effects
Are prone to dehydration, low blood pressure, or frequent fainting Are at risk for or have had diabetic ketoacidosis
Still, the magic happens gradually over the next 12 weeks as your skin naturally regenerates and produces new collagen, elastin, and hyaluronic acid
Liraglutide (Bachem) was dissolved in 0.9% saline
